Last checked at 
30 Mar 2017 13:00
BIOPHARMA CREDIT PLC
Notification of Transactions by
Persons Discharging Managerial Responsibilities and
Persons Closely Associated with them
1. | Details of person discharging managerial responsibilities/person closely associated with them | ||||||||||
a) | Name | 1. Sarah Hyman 2. Anita Hyman 3. Adam Hyman | |||||||||
2. | Reason for the notification | ||||||||||
a) | Position / status | Persons Closely Associated with Harry Hyman (Director of BioPharma Credit PLC) | |||||||||
b) | Initial notification / amendment | Initial notification | |||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||||||||
a) | Name | BioPharma Credit PLC | |||||||||
b) | LEI | 213800AV55PYXAS7SY24 | |||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||||||||
a) | Description of the financial instrument
Identification Code | Ordinary Shares of $1.00 each
GB00BDGKMY29 | |||||||||
b) | Nature of the transaction | Purchase of Ordinary Shares | |||||||||
c) | Price(s) and volume(s) |
| |||||||||
d) | Aggregated information - Aggregated volume
- Price | N/A (Separate transaction for each) | |||||||||
e) | Date of the transaction | 28.03.17 | |||||||||
f) | Place of the transaction | London Stock Exchange (XLON) | |||||||||